NASDAQ:MDCO The Medicines Price Target, Predictions & Analyst Ratings Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $84.90 0.00 (0.00 %) (As of 01/6/2020) Add Compare Share Today's Range$84.90Now: $84.90▼$84.9050-Day Range$84.90MA: $84.90▼$84.9052-Week Range$17.81Now: $84.90▼$84.98VolumeN/AAverage Volume9.55 million shsMarket Capitalization$6.77 billionP/E RatioN/ADividend YieldN/ABeta1.1 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Analyst Ratings The Medicines (NASDAQ:MDCO) Price Target and Consensus RatingMarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.6 Wall Street analysts have issued ratings and price targets for The Medicines in the last 12 months. Their average twelve-month price target is $76.50, predicting that the stock has a possible downside of 9.89%. The high price target for MDCO is $85.00 and the low price target for MDCO is $59.00. There are currently 5 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold." Today30 Days Ago90 Days Ago180 Days AgoMDCO Consensus Rating: HoldHoldBuyBuyMDCO Consensus Rating Score: 18.104.22.1682.50MDCO Analyst Ratings: 0 Sell Rating(s)5 Hold Rating(s)1 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)2 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)6 Hold Rating(s)6 Buy Rating(s)0 Strong Buy Rating(s)MDCO Consensus Price Target: $76.50$75.50$76.75$76.75MDCO Price Target Upside: 9.89% downside12.85% upside30.62% upside30.62% upsideThe Medicines (NASDAQ:MDCO) Consensus Price Target HistoryAverage Share Price and Price Target by MonthThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. The Medicines (NASDAQ:MDCO) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails11/26/2019SVB LeerinkDowngradeOutperform ➝ Market Perform$78.00 ➝ $85.00Low11/26/2019Chardan CapitalDowngradeBuy ➝ NeutralLow11/25/2019OppenheimerDowngradeOutperform ➝ Hold$68.00 ➝ $85.00High11/25/2019Robert W. BairdDowngradeOutperform ➝ Neutral$100.00 ➝ $85.00Medium11/25/2019CowenReiterated RatingBuy$60.00Low11/20/2019CitigroupReiterated RatingHold$59.00High10/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$44.00 ➝ $50.00High10/2/2019B. RileyBoost Price TargetBuy$74.00 ➝ $95.00Low9/3/2019Roth CapitalSet Price TargetBuy$72.00Low9/3/2019JPMorgan Chase & Co.Boost Price TargetOverweight$39.00 ➝ $49.00Medium9/2/2019Piper Jaffray CompaniesReiterated RatingOverweight ➝ Positive$142.00 ➝ $145.00High8/26/2019Bank of AmericaReiterated RatingBuy$51.00High4/26/2019The Goldman Sachs GroupUpgradeNeutral ➝ Buy$25.00 ➝ $55.00High12/14/2018Wolfe ResearchInitiated CoverageOutperform ➝ OutperformLow(Data available from 10/30/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.) This page was last updated on 10/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.